NF-κB activation coordinated by IKKβ and IKKε enables latent infection of Kaposi's sarcoma-associated herpesvirus

Journal of Virology

Volumn 88, Issue 1, 2014, Pages 444-455

  He, Zhiheng ^a   Zhao, Jun ^a   Zhang, Junjie ^a   Jung, Jae U ^a   Feng, Pinghui ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE BETA; I KAPPA B KINASE EPSILON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR RELA;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; LATENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION; UPREGULATION; VIRUS GENE;

CELL LINE; GENE KNOCKDOWN TECHNIQUES; HERPESVIRUS 8, HUMAN; HUMANS; I-KAPPA B KINASE; ISOENZYMES; NF-KAPPA B; PHOSPHORYLATION; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SARCOMA, KAPOSI; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION; VIRUS LATENCY;

EID: 84890964819     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01716-13     Document Type: Article

References (66)

1. Russo JJ, Bohenzky RA, Chien MC, Chen J, Yan M, Maddalena D, Parry JP, Peruzzi D, Edelman IS, Chang Y, Moore PS. 1996. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. U. S. A. 93:14862-14867.
2. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869. http://dx.doi .org/10.1126/science.7997879.
3. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 332:1186-1191.
4. Nador RG, Cesarman E, Knowles DM, Said JW. 1995. Herpes-like DNA sequences in a body-cavity-based lymphoma in an HIV-negative patient. N. Engl. J. Med. 333:943.
5. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, d'Agay MF, Clauvel JP, Raphael M, Degos L, Sigaux F. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86:1276-1280.
6. Staskus KA, Zhong W, Gebhard K, Herndier B, Wang H, Renne R, Beneke J, Pudney J, Anderson DJ, Ganem D, Haase AT. 1997. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J. Virol. 71:715-719.
7. Chiou CJ, Poole LJ, Kim PS, Ciufo DM, Cannon JS, ap Rhys CM, Alcendor DJ, Zong JC, Ambinder RF, Hayward GS. 2002. Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus. J. Virol. 76:3421-3439. http://dx.doi.org/10.1128/JVI.76.7.3421 -3439.2002.
8. Ganem D. 2006. KSHV infection and the pathogenesis of Kaposi's sarcoma. Annu. Rev. Pathol. 1:273-296. http://dx.doi.org/10.1146/annurevpathol.1 .110304.100133.
9. Zhou FC, Zhang YJ, Deng JH, Wang XP, Pan HY, Hettler E, Gao SJ. 2002. Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis. J. Virol. 76:6185-6196. http://dx.doi.org/10.1128/JVI.76 .12.6185-6196.2002.
10. Speck SH, Ganem D. 2010. Viral latency and its regulation: lessons from the gamma-herpesviruses. Cell Host Microbe 8:100-115. http://dx.doi .org/10.1016/j.chom.2010.06.014.
11. Nakamura H, Lu M, Gwack Y, Souvlis J, Zeichner SL, Jung JU. 2003. Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator. J. Virol. 77:4205-4220. http://dx.doi.org/10.1128/JVI.77.7.4205-4220.2003.
12. Jaber T, Yuan Y. 2013. A virally encoded small peptide regulates RTA stability and facilitates Kaposi's sarcoma-associated herpesvirus lytic replication. J. Virol. 87:3461-3470. http://dx.doi.org/10.1128/JVI.02746-12.
13. Jin Y, He Z, Liang D, Zhang Q, Zhang H, Deng Q, Robertson ES, Lan K. 2012. Carboxyl-terminal amino acids 1052 to 1082 of the latencyassociated nuclear antigen (LANA) interact with RBP-Jk and are responsible for LANA-mediated RTA repression. J. Virol. 86:4956-4969. http: //dx.doi.org/10.1128/JVI.06788-11.
14. Bellare P, Ganem D. 2009. Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivation. Cell Host Microbe 6:570-575. http://dx .doi.org/10.1016/j.chom.2009.11.008.
15. Liang Y, Ganem D. 2003. Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling. Proc. Natl. Acad. Sci. U. S. A. 100:8490-8495. http: //dx.doi.org/10.1073/pnas.1432843100.
16. Gwack Y, Nakamura H, Lee SH, Souvlis J, Yustein JT, Gygi S, Kung HJ, Jung JU. 2003. Poly(ADP-ribose) polymerase 1 and Ste20-like kinase hKFC act as transcriptional repressors for gamma-2 herpesvirus lytic replication. Mol. Cell. Biol. 23:8282-8294. http://dx.doi.org/10.1128/MCB .23.22.8282-8294.2003.
17. Gwack Y, Baek HJ, Nakamura H, Lee SH, Meisterernst M, Roeder RG, Jung JU. 2003. Principal role of TRAP/mediator and SWI/SNF complexes in Kaposi's sarcoma-associated herpesvirus RTA-mediated lytic reactivation. Mol. Cell. Biol. 23:2055-2067. http://dx.doi.org/10.1128/MCB.23.6 .2055-2067.2003.
18. West JT, Wood C. 2003. The role of Kaposi's sarcoma-associated herpesvirus/ human herpesvirus-8 regulator of transcription activation (RTA) in control of gene expression. Oncogene 22:5150-5163. http://dx.doi.org/10 .1038/sj.onc.1206555.
19. Staudt MR, Dittmer DP. 2007. The Rta/Orf50 transactivator proteins of the gamma-herpesviridae. Curr. Top. Microbiol. Immunol. 312:71-100. http://dx.doi.org/10.1007/978-3-540-34344-8_3.
20. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M. 1997. The IkB kinase complex (IKK) contains two kinase subunits, IKKβ and IKKk, necessary for IkB phosphorylation and NF-κB activation. Cell 91:243- 252. http://dx.doi.org/10.1016/S0092-8674(00)80406-7.
21. Chen ZJ, Parent L, Maniatis T. 1996. Site-specific phosphorylation of IkBβ by a novel ubiquitination-dependent protein kinase activity. Cell 84:853-862. http://dx.doi.org/10.1016/S0092-8674(00)81064-8.
22. Hacker H, Karin M. 2006. Regulation and function of IKK and IKK-related kinases. Sci. STKE 2006:re13. http://dx.doi.org/10.1126/stke.3572006re13.
23. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, Tschopp J. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167- 1172. http://dx.doi.org/10.1038/nature04193.
24. Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, Ikeda M, Ray SC, Gale M, Jr, Lemon SM. 2005. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc. Natl. Acad. Sci. U. S. A. 102:2992-2997. http://dx.doi .org/10.1073/pnas.0408824102.
25. Li XD, Sun L, Seth RB, Pineda G, Chen ZJ. 2005. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc. Natl. Acad. Sci. U. S. A. 102:17717-17722. http://dx.doi.org/10.1073/pnas.0508531102.
26. Yang Y, Liang Y, Qu L, Chen Z, Yi M, Li K, Lemon SM. 2007. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc. Natl. Acad. Sci. U. S. A. 104:7253-7258. http://dx.doi.org/10.1073/pnas.0611506104.
27. Dong X, Feng H, Sun Q, Li H, Wu TT, Sun R, Tibbetts SA, Chen ZJ, Feng P. 2010. Murine gamma-herpesvirus 68 hijacks MAVS and IKKk to initiate lytic replication. PLoS Pathog. 6(7):e1001001. http://dx.doi.org/10 .1371/journal.ppat.1001001.
28. Dong X, Feng P. 2011. Murine gamma herpesvirus 68 hijacks MAVS and IKKk to abrogate NFkB activation and antiviral cytokine production. PLoS Pathog. 7(11):e1002336. http://dx.doi.org/10.1371/journal.ppat.1002336.
29. Dong X, He Z, Durakoglugil D, Arneson L, Shen Y, Feng P. 2012. Murine gammaherpesvirus 68 evades host cytokine production via replication transactivator-induced RelA degradation. J. Virol. 86:1930-1941. http://dx.doi.org/10.1128/JVI.06127-11.
30. Perkins ND. 2007. Integrating cell-signalling pathways with NF-κB and IKK function. Nat. Rev. Mol. Cell Biol. 8:49-62. http://dx.doi.org/10 .1038/nrm2083.
31. Zhong H, Voll RE, Ghosh S. 1998. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell 1:661-671.
32. Neumann M, Naumann M. 2007. Beyond IkBs: alternative regulation of NF-κB activity. FASEB J. 21:2642-2654. http://dx.doi.org/10.1096/fj.06 -7615rev.
33. Huang B, Yang XD, Lamb A, Chen LF. 2010. Posttranslational modifications of NF-κB: another layer of regulation for NF-κB signaling pathway. Cell. Signal. 22:1282-1290. http://dx.doi.org/10.1016/j.cellsig.2010 .03.017.
34. Chen LF, Williams SA, Mu Y, Nakano H, Duerr JM, Buckbinder L, Greene WC. 2005. NF-κB RelA phosphorylation regulates RelA acetylation. Mol. Cell. Biol. 25:7966-7975. http://dx.doi.org/10.1128/MCB.25 .18.7966-7975.2005.
35. Brulois KF, Chang H, Lee AS, Ensser A, Wong LY, Toth Z, Lee SH, Lee HR, Myoung J, Ganem D, Oh TK, Kim JF, Gao SJ, Jung JU. 2012. Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone. J. Virol. 86:9708-9720. http://dx.doi.org/10.1128/JVI.01019-12.
36. Myoung J, Ganem D. 2011. Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction. J. Virol. Methods 174:12-21. http: //dx.doi.org/10.1016/jviromet.2011.03.012.
37. Feng H, Dong X, Negaard A, Feng P. 2008. Kaposi's sarcoma-associated herpesvirus K7 induces viral G protein-coupled receptor degradation and reduces its tumorigenicity. PLoS Pathog. 4(9):e1000157. http://dx.doi.org /10.1371/journal.ppat.1000157.
38. Feng P, Scott CW, Cho NH, Nakamura H, Chung YH, Monteiro MJ, Jung JU. 2004. Kaposi's sarcoma-associated herpesvirus K7 protein targets a ubiquitin-like/ubiquitin-associated domain-containing protein to promote protein degradation. Mol. Cell. Biol. 24:3938-3948. http://dx .doi.org/10.1128/MCB.24.9.3938-3947.2004.
39. Feng P, Everly DN, Jr, Read GS. 2001. mRNA decay during herpesvirus infections: interaction between a putative viral nuclease and a cellular translation factor. J. Virol. 75:10272-10280. http://dx.doi.org/10.1128 /JVI.75.21.10272-10280.2001.
40. Izumiya Y, Izumiya C, Hsia D, Ellison TJ, Luciw PA, Kung HJ. 2009. NF-κB serves as a cellular sensor of Kaposi's sarcoma-associated herpesvirus latency and negatively regulates K-Rta by antagonizing the RBP-Jk coactivator. J. Virol. 83:4435-4446. http://dx.doi.org/10.1128/JVI.01999-08.
41. Feng P, Park J, Lee BS, Lee SH, Bram RJ, Jung JU. 2002. Kaposi's sarcoma-associated herpesvirus mitochondrial K7 protein targets a cellular calcium-modulating cyclophilin ligand to modulate intracellular calcium concentration and inhibit apoptosis. J. Virol. 76:11491-11504. http: //dx.doi.org/10.1128/JVI.76.22.11491-11504.2002.
42. Feng P, Liang C, Shin YC, Xiaofei E, Zhang W, Gravel R, Wu TT, Sun R, Usherwood E, Jung JU. 2007. A novel inhibitory mechanism of mitochondrion- dependent apoptosis by a herpesviral protein. PLoS Pathog. 3(12):e174. http://dx.doi.org/10.1371/journal.ppat.0030174.
43. Sahin BB, Patel D, Conrad NK. 2010. Kaposi's sarcoma-associated herpesvirus ORF57 protein binds and protects a nuclear noncoding RNA from cellularRNAdecay pathways. PLoS Pathog. 6(3):e1000799. http://dx .doi.org/10.1371/journal.ppat.1000799.
44. Vieira J, O'Hearn PM. 2004. Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. Virology 325:225-240. http://dx.doi.org/10.1016/j.virol.2004.03.049.
45. Ishii KJ, Koyama S, Nakagawa A, Coban C, Akira S. 2008. Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe 3:352-363. http://dx.doi.org/10.1016/j.chom.2008.05.003.
46. Krishnan HH, Naranatt PP, Smith MS, Zeng L, Bloomer C, Chandran B. 2004. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcomaassociated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. J. Virol. 78: 3601-3620. http://dx.doi.org/10.1128/JVI.78.7.3601-3620.2004.
47. Lawrence T, Bebien M, Liu GY, Nizet V, Karin M. 2005. IKKalpha limits macrophageNF-κBactivation and contributes to the resolution of inflammation. Nature 434:1138-1143. http://dx.doi.org/10.1038/nature03491.
48. Brown HJ, Song MJ, Deng H, Wu TT, Cheng G, Sun R. 2003. NF-κB inhibits gammaherpesvirus lytic replication. J. Virol. 77:8532-8540. http: //dx.doi.org/10.1128/JVI.77.15.8532-8540.2003.
49. Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: the next generation. Cell 144:646-674. http://dx.doi.org/10.1016/j.cell.2011.02.013.
50. Hiscott J, Nguyen TL, Arguello M, Nakhaei P, Paz S. 2006. Manipulation of the nuclear factor-kB pathway and the innate immune response by viruses. Oncogene 25:6844-6867. http://dx.doi.org/10.1038/sj.onc.1209941.
51. Krug LT, Moser JM, Dickerson SM, Speck SH. 2007. Inhibition of NF-κB activation in vivo impairs establishment of gammaherpesvirus latency. PLoS Pathog. 3(1):e11. http://dx.doi.org/10.1371/journal.ppat.0030011.
52. Sadagopan S, Sharma-Walia N, Veettil MV, Raghu H, Sivakumar R, Bottero V, Chandran B. 2007. Kaposi's sarcoma-associated herpesvirus induces sustained NF-κB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression. J. Virol. 81:3949-3968. http://dx.doi.org/10.1128/JVI .02333-06.
53. Guasparri I, Keller SA, Cesarman E. 2004. KSHV vFLIP is essential for the survival of infected lymphoma cells. J. Exp. Med. 199:993-1003. http: //dx.doi.org/10.1084/jem.20031467.
54. Yu Y, Wang SE, Hayward GS. 2005. The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation. Immunity 22:59-70. http://dx.doi .org/10.1016/j.immuni.2004.11.011.
55. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T. 2003. IKKe and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4:491-496. http://dx.doi.org/10.1038/ni921.
56. Sharma S, ten Oever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148-1151. http://dx.doi.org/10.1126/science.1081315.
57. Hemmi H, Takeuchi O, Sato S, Yamamoto M, Kaisho T, Sanjo H, Kawai T, Hoshino K, Takeda K, Akira S. 2004. The roles of two IkB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J. Exp. Med. 199:1641-1650. http://dx.doi .org/10.1084/jem.20040520.
58. Tenoever BR, Ng SL, Chua MA, McWhirter SM, Garcia-Sastre A, Maniatis T. 2007. Multiple functions of the IKK-related kinase IKKe in interferon-mediated antiviral immunity. Science 315:1274-1278. http: //dx.doi.org/10.1126/science.1136567.
59. Ng SL, Friedman BA, Schmid S, Gertz J, Myers RM, Tenoever BR, Maniatis T. 2011. IkB kinase epsilon (IKKe) regulates the balance between type I and type II interferon responses. Proc. Natl. Acad. Sci. U. S. A. 108:21170-21175. http://dx.doi.org/10.1073/pnas.1119137109.
60. Mao X, Gluck N, Li D, Maine GN, Li H, Zaidi IW, Repaka A, Mayo MW, Burstein E. 2009. GCN5 is a required cofactor for a ubiquitin ligase that targets NF-κB/RelA. Genes Dev. 23:849-861. http://dx.doi.org/10 .1101/gad.1748409.
61. Wang Y, Lu X, Zhu L, Shen Y, Chengedza S, Feng H, Wang L, Jung JU, Gutkind JS, Feng P. 2013. IKK epsilon kinase is crucial for viralGproteincoupled receptor tumorigenesis. Proc. Natl. Acad. Sci. U. S. A. 110:11139- 11144. http://dx.doi.org/10.1073/pnas.1219829110.
62. Song YJ, Jen KY, Soni V, Kieff E, Cahir-McFarland E. 2006. IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-κB activation. Proc. Natl. Acad. Sci. U. S. A. 103:2689-2694. http://dx.doi.org/10.1073/pnas .0511096103.
63. Adli M, Baldwin AS. 2006. IKK-i/IKKe controls constitutive, cancer cell-associated NF-κB activity via regulation of Ser-536 p65/RelA phosphorylation. J. Biol. Chem. 281:26976-26984. http://dx.doi.org/10.1074 /jbc.M603133200.
64. Kishore N, Huynh QK, Mathialagan S, Hall T, Rouw S, Creely D, Lange G, Caroll J, Reitz B, Donnelly A, Boddupalli H, Combs RG, Kretzmer K, Tripp CS. 2002. IKK-i and TBK-1 are enzymatically distinct from the homologous enzyme IKK-2: comparative analysis of recombinant human IKK-i, TBK-1, and IKK-2. J. Biol. Chem. 277:13840-13847. http://dx.doi .org/10.1074/jbc.M110474200.
65. Huynh QK, Kishore N, Mathialagan S, Donnelly AM, Tripp CS. 2002. Kinetic mechanisms of IkB-related kinases (IKK) inducible IKK and TBK-1 differ from IKK-1/IKK-2 heterodimer. J. Biol. Chem. 277:12550- 12558. http://dx.doi.org/10.1074/jbc.M111526200.
66. Peters RT, Liao SM, Maniatis T. 2000. IKKe is part of a novel PMAinducible IkB kinase complex. Mol. Cell 5:513-522. http://dx.doi.org/10 .1016/S1097-2765(00)80445-1.